Insider Buy/Sell Ratio — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
By Sector
Technology
Buys220
Sells4346
Buy $$1.19B
Sell $$4.21B
Ratio1:3.53
% Change vs. Prior
Ratio -68.7%Value -63.3%
Healthcare
Buys185
Sells1781
Buy $$162.94M
Sell $$2.62B
Ratio1:16.08
% Change vs. Prior
Ratio +130.6%Value -66.5%
Consumer Cyclical
Buys85
Sells588
Buy $$15.39M
Sell $$1.11B
Ratio1:72.41
% Change vs. Prior
Ratio -69.1%Value -45.5%
Consumer Defensive
Buys50
Sells213
Buy $$15.36M
Sell $$1.05B
Ratio1:68.26
% Change vs. Prior
Ratio -88.8%Value +18.6%
Energy
Buys96
Sells91
Buy $$18.64M
Sell $$861.95M
Ratio1:46.24
% Change vs. Prior
Ratio +10.2%Value -72.4%
Financial Services
Buys273
Sells791
Buy $$38.30M
Sell $$791.18M
Ratio1:20.66
% Change vs. Prior
Ratio -59.6%Value -65.7%
Industrials
Buys113
Sells573
Buy $$60.32M
Sell $$454.10M
Ratio1:7.53
% Change vs. Prior
Ratio +25.9%Value -82.0%
Basic Materials
Buys32
Sells57
Buy $$9.13M
Sell $$217.92M
Ratio1:23.88
% Change vs. Prior
Ratio -77.7%Value +16.4%
Communication Services
Buys40
Sells319
Buy $$35.78M
Sell $$176.37M
Ratio1:4.93
% Change vs. Prior
Ratio +48.4%Value -79.7%
Real Estate
Buys70
Sells89
Buy $$5.54M
Sell $$66.13M
Ratio1:11.94
% Change vs. Prior
Ratio -62.0%Value -51.2%
Utilities
Buys14
Sells50
Buy $$8.63M
Sell $$49.76M
Ratio1:5.76
% Change vs. Prior
Ratio +104.7%Value -92.9%
By Industry
Biotechnology
Buys131
Sells1228
Buy $$149.47M
Sell $$1.91B
Ratio1:12.79
% Change vs. Prior
Ratio -75.7%Value +171.9%
Hardware, Equipment & Parts
Buys7
Sells807
Buy $$1.14B
Sell $$294.58M
Ratio3.87:1
% Change vs. Prior
Ratio -76.6%Value -80.2%
Software - Application
Buys169
Sells705
Buy $$41.13M
Sell $$1.15B
Ratio1:28.00
% Change vs. Prior
Ratio -63.4%Value -2.3%
Semiconductors
Buys5
Sells561
Buy $$680.36K
Sell $$1.06B
Ratio1:1562.72
% Change vs. Prior
Ratio -35.9%Value -43.2%
Software - Infrastructure
Buys12
Sells1282
Buy $$6.36M
Sell $$747.72M
Ratio1:117.62
% Change vs. Prior
Ratio -45.0%Value -56.5%
Specialty Retail
Buys22
Sells211
Buy $$2.94M
Sell $$715.69M
Ratio1:243.13
Computer Hardware
Buys0
Sells710
Buy $$0.00
Sell $$586.10M
RatioAll Sells
% Change vs. Prior
Ratio -100.0%Value -50.1%
Oil & Gas Energy
Buys0
Sells4
Buy $$0.00
Sell $$584.16M
RatioAll Sells
Restaurants
Buys0
Sells55
Buy $$0.00
Sell $$477.46M
RatioAll Sells
Medical - Healthcare Information Services
Buys2
Sells145
Buy $$391.56K
Sell $$261.87M
Ratio1:668.79
% Change vs. Prior
Ratio +73.0%Value -85.2%
Discount Stores
Buys1
Sells6
Buy $$93.31K
Sell $$252.33M
Ratio1:2704.23
Engineering & Construction
Buys5
Sells50
Buy $$502.94K
Sell $$230.13M
Ratio1:457.57
Chemicals - Specialty
Buys17
Sells32
Buy $$6.87M
Sell $$207.29M
Ratio1:30.19
Financial - Capital Markets
Buys13
Sells107
Buy $$954.78K
Sell $$208.39M
Ratio1:218.27
Information Technology Services
Buys19
Sells71
Buy $$2.46M
Sell $$205.23M
Ratio1:83.31
% Change vs. Prior
Ratio +142.4%Value -80.1%
Transactions (9072)
Valens Semiconductor Ltd. (VLN)
Chairman David — SVP, R&D
Shares
4,000
Price
$2.43
Total Value
$9.73K
Shares Held After
403,968
% of Holdings
1.0%
KENNAMETAL INC (KMT)
Bacchus Judith L — Vice President
Shares
5,488
Price
$35.94
Total Value
$197.24K
Shares Held After
4,554
% of Holdings
54.7%
Allot Ltd. (ALLT)
Shteiman Mark — Chief Product Officer
Shares
2,000
Price
$7.50
Total Value
$15.00K
Shares Held After
212,000
% of Holdings
0.9%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Reynoso Jamie L. — CEO, Medicare Advantage
Shares
6,350
Price
$4.61
Total Value
$29.27K
Shares Held After
2,843,571
% of Holdings
0.2%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Soares Karen — Chief Legal Officer
Shares
4,681
Price
$4.61
Total Value
$21.58K
Shares Held After
1,567,741
% of Holdings
0.3%
WORLD ACCEPTANCE CORP (WRLD)
Caulder Alice Lindsay — SVP, Human Resources
Shares
609
Price
$181.00
Total Value
$110.23K
Shares Held After
14,682
% of Holdings
4.0%
111, Inc. (YI)
Sun Jian David — Director
Shares
58,800
Price
$0.23
Total Value
$13.52K
Shares Held After
413,211
% of Holdings
12.5%
111, Inc. (YI)
Chen Yang Luke — Director
Shares
44,000
Price
$0.23
Total Value
$10.12K
Shares Held After
495,462
% of Holdings
8.2%
Shares
2,470
Price
$87.80
Total Value
$216.87K
Shares Held After
90,000
% of Holdings
2.7%
Shares
6,845
Price
$87.20
Total Value
$596.88K
Shares Held After
92,470
% of Holdings
6.9%
Shares
685
Price
$85.97
Total Value
$58.89K
Shares Held After
99,315
% of Holdings
0.7%
TIGO ENERGY, INC. (TYGO)
Manor Sagit — Director
Shares
63,500
Price
$2.85
Total Value
$180.97K
Shares Held After
323,098
% of Holdings
16.4%
Viant Technology Inc. (DSP)
Vanderhook Christopher — Director
Shares
9,125
Price
$11.10
Total Value
$101.29K
Shares Held After
293,880
% of Holdings
3.0%
Viant Technology Inc. (DSP)
MADDEN LARRY — Chief Financial Officer
Shares
25,376
Price
$11.10
Total Value
$281.67K
Shares Held After
459,155
% of Holdings
5.2%
Viant Technology Inc. (DSP)
Vanderhook Timothy — Director
Shares
9,125
Price
$11.10
Total Value
$101.29K
Shares Held After
208,880
% of Holdings
4.2%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
3,666
Price
$3.58
Total Value
$13.12K
Shares Held After
132,715
% of Holdings
2.7%
Navan, Inc. (NAVN)
Lightspeed Venture Partners Select II, L.P. — 10% Owner
Shares
430,659
Price
$20.62
Total Value
$8.88M
Shares Held After
2,756,858
% of Holdings
13.5%
Navan, Inc. (NAVN)
Lightspeed Venture Partners Select II, L.P. — 10% Owner
Shares
573,572
Price
$20.19
Total Value
$11.58M
Shares Held After
3,187,517
% of Holdings
15.3%
Navan, Inc. (NAVN)
Lightspeed Venture Partners X, L.P. — 10% Owner
Shares
430,659
Price
$20.62
Total Value
$8.88M
Shares Held After
2,756,858
% of Holdings
13.5%
Navan, Inc. (NAVN)
Lightspeed Venture Partners X, L.P. — 10% Owner
Shares
573,572
Price
$20.19
Total Value
$11.58M
Shares Held After
3,187,517
% of Holdings
15.3%
Navan, Inc. (NAVN)
Janmohamed Arif — Director
Shares
430,659
Price
$20.62
Total Value
$8.88M
Shares Held After
2,756,858
% of Holdings
13.5%
Navan, Inc. (NAVN)
Janmohamed Arif — Director
Shares
573,572
Price
$20.19
Total Value
$11.58M
Shares Held After
3,187,517
% of Holdings
15.3%
Alignment Healthcare, Inc. (ALHC)
Maroney Dawn Christine — President
Shares
30,000
Price
$19.55
Total Value
$586.42K
Shares Held After
947,313
% of Holdings
3.1%
ABEONA THERAPEUTICS INC. (ABEO)
Silverstein Christine Berni — Director
Shares
18,160
Price
$5.71
Total Value
$103.70K
Shares Held After
119,562
% of Holdings
13.2%
C3.ai, Inc. (AI)
SIEBEL THOMAS M — Director
Shares
472,005
Price
$11.11
Total Value
$5.24M
Shares Held After
722,362
% of Holdings
39.5%
SITIME Corp (SITM)
Bonnot Lionel — Executive Vice President, Worldwide Sales and Business Development
Shares
500
Price
$736.02
Total Value
$368.01K
Shares Held After
72,797
% of Holdings
0.7%
SITIME Corp (SITM)
VASHIST RAJESH — Director
Shares
5,000
Price
$750.00
Total Value
$3.75M
Shares Held After
9,781
% of Holdings
33.8%
SITIME Corp (SITM)
VASHIST RAJESH — Director
Shares
15,000
Price
$750.20
Total Value
$11.25M
Shares Held After
387,898
% of Holdings
3.7%
Nebius Group N.V. (NBIS)
Boynton John Wilson IV — Director
Shares
100
Price
$262.09
Total Value
$26.21K
Shares Held After
428,098
% of Holdings
0.0%
Nebius Group N.V. (NBIS)
Boynton John Wilson IV — Director
Shares
900
Price
$260.76
Total Value
$234.68K
Shares Held After
379,271
% of Holdings
0.2%
Nebius Group N.V. (NBIS)
Boynton John Wilson IV — Director
Shares
606
Price
$259.45
Total Value
$157.23K
Shares Held After
378,665
% of Holdings
0.2%
Nebius Group N.V. (NBIS)
Boynton John Wilson IV — Director
Shares
100
Price
$257.54
Total Value
$25.75K
Shares Held After
429,704
% of Holdings
0.0%
Nebius Group N.V. (NBIS)
Boynton John Wilson IV — Director
Shares
200
Price
$255.03
Total Value
$51.01K
Shares Held After
429,804
% of Holdings
0.0%
Nebius Group N.V. (NBIS)
Boynton John Wilson IV — Director
Shares
200
Price
$253.58
Total Value
$50.72K
Shares Held After
380,471
% of Holdings
0.1%
Nebius Group N.V. (NBIS)
Boynton John Wilson IV — Director
Shares
200
Price
$251.89
Total Value
$50.38K
Shares Held After
430,204
% of Holdings
0.0%
Nebius Group N.V. (NBIS)
Boynton John Wilson IV — Director
Shares
3,206
Price
$250.08
Total Value
$801.76K
Shares Held After
380,871
% of Holdings
0.8%
Nebius Group N.V. (NBIS)
Boynton John Wilson IV — Director
Shares
200
Price
$248.73
Total Value
$49.75K
Shares Held After
384,077
% of Holdings
0.1%
Nebius Group N.V. (NBIS)
Boynton John Wilson IV — Director
Shares
100
Price
$246.17
Total Value
$24.62K
Shares Held After
433,810
% of Holdings
0.0%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
600
Price
$69.69
Total Value
$41.81K
Shares Held After
236,384
% of Holdings
0.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
733
Price
$69.69
Total Value
$51.08K
Shares Held After
31,034
% of Holdings
2.3%
Ultragenyx Pharmaceutical Inc. (RARE)
Parschauer Karah Herdman — EVP and Chief Legal Officer
Shares
1,899
Price
$24.62
Total Value
$46.75K
Shares Held After
94,462
% of Holdings
2.0%
LINCOLN EDUCATIONAL SERVICES CORP (LINC)
LUSTER ALEXANDRA M — SVP and General Counsel
Shares
18,007
Price
$44.64
Total Value
$803.83K
Shares Held After
82,356
% of Holdings
17.9%
Block, Inc. (XYZ)
Eisen Anthony Mathew — Director
Shares
6,000
Price
$72.26
Total Value
$433.56K
Shares Held After
1,972,990
% of Holdings
0.3%
Ultragenyx Pharmaceutical Inc. (RARE)
Sanders Corazon (Corsee) D. — Director
Shares
2,000
Price
$25.05
Total Value
$50.10K
Shares Held After
21,095
% of Holdings
8.7%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
1,729
Price
$69.69
Total Value
$120.49K
Shares Held After
925,580
% of Holdings
0.2%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
947
Price
$69.69
Total Value
$66.00K
Shares Held After
32,718
% of Holdings
2.8%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
300
Price
$70.62
Total Value
$21.19K
Shares Held After
33,665
% of Holdings
0.9%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
5,064
Price
$69.42
Total Value
$351.55K
Shares Held After
33,965
% of Holdings
13.0%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
1,636
Price
$68.38
Total Value
$111.88K
Shares Held After
39,029
% of Holdings
4.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
395
Price
$69.69
Total Value
$27.53K
Shares Held After
16,899
% of Holdings
2.3%
Showing 3251–3300 of 9072 transactions (page 66 of 182)